Anhui Anke Biotechnology (Group) Co Ltd (300009):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anhui Anke Biotechnology (Group) Co Ltd (300009) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7944
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anhui Anke Biotechnology (Group) Co Ltd (Anhui) is a developer, manufacturer and distributor of healthcare and pharmaceutical products. The company’s products include diagnostic products, genetic engineering products, polypeptide APIs, biochemistry products, precision medicine, synthetic medicines, biomedical products, and modern Chinese herb medicines. It also provides series of recombinant human interferon alpha 2b, recombinant human growth hormone, and MAR kit for anti-sperm antibody. AnkeBio’s products are used in the treatment of leukemia, nutritional support, tumor, chronic hepatitis B, burn wounds and immunopurification sterility, among others. The company also conducts research and development for recombinant drugs, pharmaceutical formulation, immunological and traditional Chinese medicines, and chemical medicine. AnkeBio is headquartered in Hefei, China.

Anhui Anke Biotechnology (Group) Co Ltd (300009) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Anhui Anke Biotechnology to Form Joint Venture with PersonGen Biomedicine 11
Licensing Agreements 12
Anhui Anke Receives Technology from Lyvgen Biopharma 12
Equity Offering 13
Anhui Anke Biotech Plans to Raise up to USD157 Million in Private Placement of Shares 13
Anhui Anke Biotech Plans to Raise USD16.4 Million in Private Placement 14
Acquisition 15
Anhui Anke Biotechnology to Acquire 30% Stake in Hubei-Based Bio-Tech Firm for USD22.64 Million 15
Anhui Anke Biotech to Acquire 30% Stake in Biotechnology Company for USD15.6 Million 16
Anhui Anke Biotech Plans to Sell its Zhejiang-Based Pharma Unit for USD2.7 Million 17
Anhui Anke Biotech Acquires Wuxi German Midland Biotech for USD73 Million 18
Anhui Anke Biotech Plans to Acquire Shanghai Soho-yiming Pharma for USD65.7 Million 19
Anhui Anke Biotechnology (Group) Co Ltd – Key Competitors 20
Anhui Anke Biotechnology (Group) Co Ltd – Key Employees 21
Anhui Anke Biotechnology (Group) Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anhui Anke Biotechnology to Form Joint Venture with PersonGen Biomedicine 11
Anhui Anke Receives Technology from Lyvgen Biopharma 12
Anhui Anke Biotech Plans to Raise up to USD157 Million in Private Placement of Shares 13
Anhui Anke Biotech Plans to Raise USD16.4 Million in Private Placement 14
Anhui Anke Biotechnology to Acquire 30% Stake in Hubei-Based Bio-Tech Firm for USD22.64 Million 15
Anhui Anke Biotech to Acquire 30% Stake in Biotechnology Company for USD15.6 Million 16
Anhui Anke Biotech Plans to Sell its Zhejiang-Based Pharma Unit for USD2.7 Million 17
Anhui Anke Biotech Acquires Wuxi German Midland Biotech for USD73 Million 18
Anhui Anke Biotech Plans to Acquire Shanghai Soho-yiming Pharma for USD65.7 Million 19
Anhui Anke Biotechnology (Group) Co Ltd, Key Competitors 20
Anhui Anke Biotechnology (Group) Co Ltd, Key Employees 21
Anhui Anke Biotechnology (Group) Co Ltd, Subsidiaries 22
Anhui Anke Biotechnology (Group) Co Ltd, Joint Venture 22

List of Figures
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anhui Anke Biotechnology (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anhui Anke Biotechnology (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Anhui Anke Biotechnology (Group) Co Ltd (300009):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hill-Rom Holdings Inc (HRC):企業の財務・戦略的SWOT分析
    Hill-Rom Holdings Inc (HRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • South Broward Hospital District:企業の戦略的SWOT分析
    South Broward Hospital District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …
  • Ono Pharmaceutical Co Ltd (4528)-医療機器分野:企業M&A・提携分析
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of diseases such as type I …
  • Premier Marketing Public Company Limited:企業の戦略・SWOT・財務情報
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Hellenic Telecommunications Organization SA (HTO):企業の財務・戦略的SWOT分析
    Hellenic Telecommunications Organization SA (HTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • QIAGEN N.V.:企業の戦略・SWOT・財務情報
    QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report Summary QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Rizzani de Eccher S.p.A.:企業の戦略・SWOT・財務情報
    Rizzani de Eccher S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Rizzani de Eccher S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Catholic United Financial:企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Genesis Energy Ltd (GNE):電力:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …
  • Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析
    Summary Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MimiVax LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary MimiVax LLC (MimiVax) is a pharmaceutical company that discovers and develops immunotherapeutic vaccines and targeted therapies for the treatment of cancer. The company’s lead candidate is SurVaxM. Its SurVaxM is a cancer vaccine that stimulates a potent immune response and the survivin mole …
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆